Kalaris Therapeutics (KLRS) Stock Chart & Stock Price History $2.51 +0.05 (+2.03%) As of 08/22/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsOwnershipSEC FilingsTrendsBuy This Stock Kalaris Therapeutics Stock Price Performance The Kalaris Therapeutics (KLRS) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has decreased 9.39%, reflecting recent market activity. As of the latest close, Kalaris Therapeutics traded at $2.51 with a market cap of $46.94 million and volume of 67,709 shares. Receive KLRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kalaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.40%1 Month Performance-9.39% KLRS Stock Chart for Saturday, August, 23, 2025 KLRS Chart by TradingView Kalaris Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$2.46$2.51+2.03%$2.58$2.3767,709 shs$46.94 million08/21/2025$2.57$2.46-4.28%$2.55$2.4410,797 shs$46.00 million08/20/2025$2.57$2.57$2.64$2.4728,661 shs$48.06 million08/19/2025$2.50$2.57+2.80%$2.64$2.4424,846 shs$48.06 million08/18/2025$2.46$2.50+1.63%$2.60$2.3655,249 shs$46.75 million08/15/2025$2.27$2.46+8.37%$2.48$2.3178,601 shs$46.00 million08/14/2025$2.28$2.27-0.44%$2.32$2.1475,076 shs$42.45 million08/13/2025$2.49$2.28-8.43%$2.58$2.20113,328 shs$42.64 million08/12/2025$2.66$2.49-6.39%$2.59$2.4661,997 shs$46.56 million08/11/2025$2.67$2.66-0.37%$2.70$2.5512,097 shs$49.75 million Get the Latest News and Ratings for KLRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kalaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$2.71$2.67-1.48%$2.71$2.5428,903 shs$49.93 million08/07/2025$2.64$2.71+2.65%$2.79$2.6027,651 shs$50.68 million08/06/2025$2.55$2.64+3.53%$2.77$2.5472,103 shs$49.37 million08/05/2025$2.58$2.55-1.16%$2.68$2.4648,185 shs$47.69 million08/04/2025$2.69$2.58-4.09%$2.66$2.4669,652 shs$48.25 million08/01/2025$2.68$2.69+0.37%$2.75$2.5652,807 shs$50.31 million07/31/2025$2.69$2.68-0.37%$2.96$2.6219,055 shs$50.12 million07/30/2025$2.69$2.69$2.82$2.6915,174 shs$50.30 million07/29/2025$2.92$2.69-7.88%$2.97$2.6572,827 shs$50.31 million07/28/2025$2.76$2.92+5.80%$2.97$2.7832,006 shs$54.60 million07/25/2025$2.84$2.76-2.82%$2.96$2.6641,291 shs$51.61 million07/24/2025$2.77$2.84+2.53%$2.96$2.7837,505 shs$53.11 million07/23/2025$2.57$2.77+7.78%$2.97$2.53132,939 shs$51.81 million07/22/2025$2.42$2.57+6.20%$2.59$2.41148,218 shs$48.06 million Related Companies NLTX Stock Chart TRDA Stock Chart OGI Stock Chart IPHA Stock Chart GNFT Stock Chart CTMX Stock Chart EPRX Stock Chart ENGN Stock Chart EDIT Stock Chart SXTC Stock Chart Receive KLRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kalaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KLRS) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kalaris Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kalaris Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access